טוען...
Current status of immune checkpoint inhibitors in treatment of non-small cell lung cancer
Lung cancer remains a leading cause of cancer mortality worldwide, including in Korea. Systemic therapy including platinum-based chemotherapy and targeted therapy should be provided to patients with stage IV non-small cell lung cancer (NSCLC). Applications of targeted therapy, such as an epidermal g...
שמור ב:
| הוצא לאור ב: | Korean J Intern Med |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
The Korean Association of Internal Medicine
2019
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6325449/ https://ncbi.nlm.nih.gov/pubmed/30612418 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3904/kjim.2018.179 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|